Patents Represented by Attorney Mueting, Raasch & Gebhardt, P.A.
  • Patent number: 8343539
    Abstract: The present invention provides biologically active compounds that bind an ?5?1 integrin. Also included in the present invention are methods for using such biologically active compounds.
    Type: Grant
    Filed: July 13, 2007
    Date of Patent: January 1, 2013
    Assignee: Regents of the University of Minnesota
    Inventors: Efrosini Kokkoli, Anastasia Mardilovich, Ashish Garg
  • Patent number: 8342440
    Abstract: Miniature robotic vehicles suitable for a variety of tasks including covert surveillance, reconnaissance, and recreation are provided. Embodiments of the invention may include vehicles having a hybrid transportation system that incorporates a rotary-wing flight mode in conjunction with a wheeled ground transport mode. As a result, exemplary vehicles provide efficient ground-mode travel, with the added ability to fly over large obstacles and rough terrain.
    Type: Grant
    Filed: December 7, 2010
    Date of Patent: January 1, 2013
    Assignee: Regents of the University of Minnesota
    Inventors: Nikolaos P. Papanikolopoulos, Alex J. Kossett
  • Patent number: 8338433
    Abstract: The present invention provides methods of killing, inhibiting the growth, and/or inhibiting the reproduction of kine-toplastid or apicomplexan protozoan with tyrosine kinase inhibitors.
    Type: Grant
    Filed: November 21, 2007
    Date of Patent: December 25, 2012
    Assignee: University of Georgia Research Foundation, Inc.
    Inventor: Kojo Mensa-Wilmot
  • Patent number: 8335058
    Abstract: A magnetic sensor includes a reference layer having a first magnetization direction and a free layer assembly having an effective magnetization direction substantially perpendicular to the first magnetization direction and substantially perpendicular to a plane of each layer of the free layer assembly. A spacer layer is between the reference layer and the free layer, and a signal enhancement layer is exchange coupled to the free layer assembly on a side opposite the spacer layer.
    Type: Grant
    Filed: March 15, 2011
    Date of Patent: December 18, 2012
    Assignee: Seagate Technology LLC
    Inventors: Song S. Xue, Zheng Gao, Shaoping Li, Kaizhong Gao, Dimitar V. Dimitrov, Konstantin Nikolaev, Patrick J. Ryan
  • Patent number: 8334259
    Abstract: Endothelial dysfunction (ED) is associated with a number of diseases and disorders. Agonists of the non-proteolytically activated thrombin receptor can be used in methods to treat ED or ED-related diseases and disorders.
    Type: Grant
    Filed: September 21, 2007
    Date of Patent: December 18, 2012
    Assignees: The Board of Regents, The University of Texas System, The Texas A&M University System
    Inventors: Darrell H. Carney, Barbara Olszewska-Pazdrak, Theresa W. Fossum
  • Patent number: 8329192
    Abstract: The present invention provides isolated metal regulated polypeptides obtainable from a Campylobacter spp., and compositions including the polypeptides. The present invention also includes methods for using the compositions disclosed herein, including methods for treating in infection in a subject, for treating a condition caused by a Campylobacter spp., and for decreasing colonization of an animal.
    Type: Grant
    Filed: September 20, 2004
    Date of Patent: December 11, 2012
    Assignee: Epitopix LLC
    Inventors: Darren E. Straub, Daryll A. Emery
  • Patent number: 8331051
    Abstract: A disc drive system provides increased reliability by detecting and correcting errors associated with bit-patterned media. Write synchronization errors associated with bit-patterned media are addressed by including data storage for temporarily storing data that is being written to the disc drive. The data is read from both the disc drive and the storage medium and compared to detect write synchronization errors. The disc drive system utilizes the identified write synchronization errors for at least one of timing recovery, equalizer training detection, error correction code application, and error recovery.
    Type: Grant
    Filed: October 14, 2010
    Date of Patent: December 11, 2012
    Assignee: Seagate Technology LLC
    Inventors: Michael L. Mallary, Mehmet F. Erden, Ching He, Venkata S. Chilaka
  • Patent number: 8329411
    Abstract: A sensitive, multicomponent diagnostic test for infection with T. cruzi, the causative agent of Chagas disease, including methods of making and methods of use. Also provided is a method for screening T. cruzi polypeptides to identify antigenic polypeptides for inclusion as components of the diagnostic test, as well as compositions containing antigenic T. cruzi polypeptides.
    Type: Grant
    Filed: July 30, 2008
    Date of Patent: December 11, 2012
    Assignee: University of Georgia Research Foundation, Inc.
    Inventors: Rick L. Tarleton, Ronald D. Etheridge, Jr.
  • Patent number: 8323755
    Abstract: Nematic liquid crystal cells with positive dielectric anisotropy that include colloidal suspensions having nanoclusters (e.g., CdTe nanoclusters, CdSe nanoclusters) that include a pure monolayer of ligands are provided as well as methods of inducing Freedericksz transitions in the nematic liquid crystal cells and methods of controlling the alignment of a liquid crystal.
    Type: Grant
    Filed: February 22, 2010
    Date of Patent: December 4, 2012
    Assignee: University of Manitoba
    Inventors: Torsten Hegmann, Brandy Melissa Kinkead
  • Patent number: 8324607
    Abstract: A memory comprising at least one memory cell operationally connected to a bit line, a source line and a word line. The memory cell comprises a substrate having a first source contact, a second source contact, and a bit contact between the first source contact and the second source contact, a first transistor gate electrically connecting the first source contact and the bit contact and a second transistor gate electrically connecting the bit contact and the second source contact. The word line electrically connects the first transistor gate to the second transistor gate.
    Type: Grant
    Filed: October 25, 2011
    Date of Patent: December 4, 2012
    Assignee: Seagate Technology LLC
    Inventors: Roger Glenn Rolbiecki, Andrew Carter, Yong Lu
  • Patent number: 8324344
    Abstract: Isolated polypeptides, nucleic acids, and methods relating to cellular internalization of materials are described herein. Generally, the isolated polypeptides include a membrane transduction domain of human tissue factor pathway inhibitor-2 (TFPI-2). In some cases, the isolated polypeptide can be a fusion peptide that includes a membrane transduction domain of human TFPI-2 and a heterologous peptide domain. The nucleic acids include nucleic acids that encode the isolated polypeptides described herein. The methods generally include providing a composition that includes a membrane transduction domain of human TFPI-2 coupled to a material, and contacting the composition with a cell under conditions effective to permit the cell to internalize the composition.
    Type: Grant
    Filed: October 7, 2009
    Date of Patent: December 4, 2012
    Assignee: STC.UNM
    Inventor: Walter Kisiel
  • Patent number: 8318636
    Abstract: Methods according to the invention administering one or more rice rhizosphere isolates to a plant, particularly a rice plant, to the seed of the plant, or to soil surrounding the plant in an amount effective to inhibit infection by a plant pathogen, particularly rice blast, to increase the biomass of the plant, and/or to decrease arsenic uptake by the plant.
    Type: Grant
    Filed: March 1, 2011
    Date of Patent: November 27, 2012
    Assignee: University of Delaware
    Inventors: Harsh Bais, Darla Janine Sherrier, Emily Alff
  • Patent number: 8314445
    Abstract: A thin-film plasmonic device including a layer of a conductive material positioned over an array of electrodes of alternating polarity.
    Type: Grant
    Filed: March 10, 2011
    Date of Patent: November 20, 2012
    Assignee: University of Manitoba
    Inventors: Sergei Rudenja, Michael S. Freund
  • Patent number: 8294838
    Abstract: Nematic liquid crystal cells with positive dielectric anisotropy that include colloidal suspensions having nanoclusters are provided as well as methods of inducing Freedericksz transitions therein and methods of controlling the alignment of a liquid crystal.
    Type: Grant
    Filed: May 2, 2008
    Date of Patent: October 23, 2012
    Assignee: University of Manitoba
    Inventors: Torsten Hegmann, Hao Qi
  • Patent number: 8287535
    Abstract: Apparatus and methods for internal surgical procedures are disclosed. The apparatus and methods may involve supporting internal body locations, creating submucosal separations (blebs), and/or for resecting mucosal tissue separated from underlying tissue by a bleb.
    Type: Grant
    Filed: May 11, 2006
    Date of Patent: October 16, 2012
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Jose G. de la Mora Levy, Christopher J. Gostout
  • Patent number: 8281952
    Abstract: A container incorporating an integral roller surface for use with a roller-type liquid applicator. The roller surface may be movable from a first, operational position to a second, access position. The floor of the container may be sloped so that a well forms at a particular location, e.g., at or near one end of the container. The roller surface preferably provides access to the well during use. When the roller surface is moved to the second, access position, the sloped floor of the container may provide a second roller surface.
    Type: Grant
    Filed: January 15, 2004
    Date of Patent: October 9, 2012
    Assignee: Valspar Sourcing, Inc.
    Inventors: James R. Robellard, Steven D. Person, Gary F. Prokop, Randall P. Bell, Mark D. Kiel, Allen B. McKittrick
  • Patent number: 8282941
    Abstract: The present invention provides compositions including siderophore receptor polypeptides from gram negative microbes, and preferably, lipopolysaccarhide at a concentration of no greater than about 10.0 endotoxin units per milliliter. The present invention also provides methods of making and methods of using such compositions.
    Type: Grant
    Filed: April 21, 2011
    Date of Patent: October 9, 2012
    Assignee: Epitopix, LLC
    Inventors: Daryll A. Emery, Darren E. Straub
  • Patent number: 8281857
    Abstract: Fluid compositions and methods of making and using same are described, one composition comprising a well treatment fluid and an additive combined with the well treatment fluid, wherein the additive is selected from solids, liquids and combinations thereof, the additive having a surface shape, at least one property of the surface shape enabling it to change under influence of a controllable parameter after the composition is deployed into a hydraulic fracture or gravel pack. In methods of the disclosure, the additive exists initially in a first state, and then is changed to a second state. The first state may increase proppant flowback efficiency, while the second state may increase hydraulic conductivity. In certain embodiments, the additive may change back to its first state.
    Type: Grant
    Filed: December 5, 2008
    Date of Patent: October 9, 2012
    Assignees: 3M Innovative Properties Company, Schlumberger Technology Corporation
    Inventors: Dean Michael Willberg, James G. Carlson, Ignatius A. Kadoma, Yong K. Wu, Michael D. Crandall
  • Patent number: 8277821
    Abstract: The present invention provides compositions including siderophore receptor polypeptides and porins from gram negative microbes, and preferably, lipopolysaccarhide at a concentration of no greater than about 10.0 endotoxin units per milliliter. The present invention also provides methods of making and methods of using such compositions.
    Type: Grant
    Filed: April 21, 2011
    Date of Patent: October 2, 2012
    Assignee: Epitopix, LLC
    Inventors: Daryll A. Emery, Darren E. Straub
  • Patent number: D669966
    Type: Grant
    Filed: July 1, 2011
    Date of Patent: October 30, 2012
    Assignee: Alternative Energy, Inc.
    Inventor: Steven W. Claussen